• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Strides Pharma Science Limited — Board Meeting, 30-01-2026: Outcome of Board Meeting

    30-01-2026 | 12:48 pm

    Strides Pharma's Board approved Q3 FY26 consolidated financial results. Revenue from operations hit Rs. 1,194.65 Cr, with a PAT of Rs. 208.12 Cr. EPS stood at Rs. 21.93. The company also booked a Rs. 102.14 Cr profit from selling an investment property.

    No comments yet. Be the first to comment!

    All announcements from Strides Pharma Science Limited